Broad Experience, Track Records of Success Position Company for
Global Growth, Commercialization
REDWOOD CITY, Calif.--(BUSINESS WIRE)--
HeartFlow, Inc. today announced the recent appointment of several key
executives including Baird Radford, as chief financial officer; Brent
Ness, as chief commercial officer; Robert Eno, as vice president of
marketing; and Yoshiki Kawabata, as president of HeartFlow Japan GK.
“This team shares broad experience and significant track records of
success in bringing to market some of our era’s most innovative
technologies, across multiple fields and specialties. As a company, we
share a vision of improving patient outcomes and experiences and
reducing costs to the health care system,” said John H. Stevens, M.D.,
chairman and CEO of HeartFlow. “These individuals provide the exact
experience and skills needed as we prepare to become a global,
commercial stage company. I am thrilled to welcome Baird, Brent, Rob and
Yoshiki to the HeartFlow family.”
Baird Radford has more than 20 years of public company finance
experience in Silicon Valley. Prior to joining HeartFlow, Mr. Radford
served as vice president of finance at Intuitive Surgical, Inc., with
responsibility for financial planning and analysis, investor relations,
and enterprise analytics. Prior to Intuitive Surgical, Mr. Radford held
various positions at eBay, Inc., including vice president of finance for
Marketplaces Europe, as well as vice president, corporate controller,
and chief accounting officer. Mr. Radford also worked in the audit
practice of PricewaterhouseCoopers LLP. He received his B.B.A. from Ohio
Brent Ness has more than 25 years of experience in commercial and
executive roles in health care. Prior to joining HeartFlow Mr. Ness
served as president and chief commercial officer of ProNerve LLC, a
leader in the field of Intraoperative Neurophysiological Monitoring
(IOM), and as vice president of global sales and marketing for Medtronic
Navigation. Prior to Medtronic, Mr. Ness held the positions of vice
president of sales operations North America for Philips and corporate
director of corporate accounts for GE Healthcare. He earned an M.B.A.
from the University of Colorado and a B.S. from the University of North
Robert Eno has 20 years of experience in bringing disruptive medical
technologies to market. Prior to joining HeartFlow, he held the position
of vice president of marketing and international sales at OptiMedica,
which was acquired by Abbott. Previously, he served as vice president of
marketing at NeoGuide Systems (acquired by Intuitive Surgical) and as
vice president of sales and marketing at Avantec Vascular (acquired by
Goodman Co. Ltd). He also held several marketing and strategic planning
positions at Guidant Corporation (acquired by Abbott). He received his
M.B.A. degree from Stanford University’s Graduate School of Business and
his A.B. from Stanford University, where he was Phi Beta Kappa.
Yoshiki Kawabata has more than 25 years of experience in a variety of
medical device businesses including surgical staplers, endoscopic
devices, electrophysiology ablation products, cardiac intervention
catheters, fractional flow reserve and optical coherence tomography
devices and in vitro diagnostics products. Prior to joining HeartFlow,
he held the position of senior director of business development and
alliances at Adachi, Co., Ltd. He has held multiple roles in sales,
marketing, business development, R&D, and franchise management at St.
Jude Medical, Johnson & Johnson, Baxter, and Century Medical in Japan.
He received his B.S. degree in Law from Rikkyo University.
About HeartFlow, Inc.
Founded in 2007, HeartFlow, Inc., is a cardiovascular company based in
Redwood City, Calif. A pioneer in the field of non-invasive coronary
artery disease diagnosis, HeartFlow is committed to developing
technology designed to help physicians noninvasively diagnose coronary
artery disease and improve patient outcomes while reducing health care
costs. For more information visit www.heartflow.com.
for HeartFlow, Inc.
Nicole Osmer, 650-454-0504
Source: HeartFlow, Inc.